Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.62
+0.99512.96%
Volume:31.48K
Turnover:1.09M
Market Cap:111.48M
PE:- -
High:34.68
Open:33.80
Low:33.71
Close:33.62
52wk High:36.84
52wk Low:25.00
Shares:3.22M
Float Shares:3.22M
Volume Ratio:0.39
T/O Rate:0.98%
Dividend:0.39
Dividend Rate:1.13%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Regeneron’s ALN-F1202 Safety Trial Marks a Quiet but Important Pipeline Milestone

TIPRANKS
·
Oct 01

Pre-Holiday Gains: Can This Strong Sector Keep Rising After the Break?

Deep News
·
Sep 30

China Pharma Sector Divergence Deepens as Innovative Drug Leaders Ride BD Second Growth Curve

Deep News
·
Sep 30

MiNK selected for ARPA-H-Funded initiative to advance room-temp cell therapy

TIPRANKS
·
Sep 30

Citi Tells Investors It's Time to Sell Moderna After 600%-Plus Stock Gains

Dow Jones
·
Sep 30

Pre-Holiday Rally: Can This Strong Sector Continue to Rise After the Break?

Deep News
·
Sep 30

ETF Daily Report (09.30): ESMO Data Expectations and BD Momentum Lift Vaccine and Innovative Drug Sectors, Semiconductor Stocks Retreat Broadly

Stock News
·
Sep 30

Sino Biopharmaceutical Stock Rises 2.9% in Hong Kong

Dow Jones
·
Sep 30

Moderna Inc. Stock Climbs 3.1%, Outperforms Peers

Dow Jones
·
Sep 30

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 30

Regeneron Needs 'Better' Terms in Sanofi Renegotiation, RBC Says

MT Newswires Live
·
Sep 30

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-09-29

Reuters
·
Sep 29

Hong Kong Stock Market Commentary: Housing Interest Subsidy Boosts Property Stocks, Innovative Drugs See Dense Catalysts

Stock News
·
Sep 29

Hong Kong Stock Connect Innovative Drug Sector Defies Market Downturn as Top Pharmaceutical Firm Enters with US$2 Billion, Akeso Surges 15.54%, Hengrui Pharma Secures US$2.6 Billion BD Deal

Deep News
·
Sep 29

Multiple Positive Catalysts Converge: Are Innovative Drugs Still the Focus for the Fourth Quarter?

Deep News
·
Sep 29

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Ocular Therapeutix (OCUL) and Regeneron (REGN)

TIPRANKS
·
Sep 29

Court Dismisses Regeneron Pharmaceuticals (REGN) Securities Lawsuit Over Eylea and Eylea HD Claims

TIPRANKS
·
Sep 29

CSPC Pharma's JMT206 Injection Ib Phase Trial for Weight Management in Overweight or Obese Adults Officially Launches at First Site in China

Stock News
·
Sep 29

CSPC Pharma's Recombinant Shingles Vaccine SYS 6052 Gains US Clinical Trial Approval

Stock News
·
Sep 29

Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Envista Holdings (NVST) and Regeneron (REGN)

TIPRANKS
·
Sep 29